Global Diabetic Neuropathy Market 2014-2018 Reportstack Reportstack Contact contactus@reportstack.com
Summary Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used. The analysts forecast the Global Diabetic Neuropathy market is expected to grow at a CAGR of 8.41 percent over the period 2014-2018. This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. The Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years. Reportstack Contact contactus@reportstack.com
Key Regions • • •
Americas EMEA APAC
• • •
Key Vendors Eli Lilly and Co. Janssen Pharmaceuticals Inc. Pfizer Inc.
• • •
Other Prominent Vendors Actavis plc Cephalon Inc. MEDA Pharma GmbH & Co. KG
Reportstack Contact contactus@reportstack.com
Market Driver • •
Increasing Global Diabetic Population. For a full, detailed list, view our report.
• •
Key Market Challenge High Failure Rate in Clinical Trials. For a full, detailed list, view our report.
• •
Key Market Trend Increasing R&D Activities. For a full, detailed list, view our report.
Reportstack Contact contactus@reportstack.com
Key Questions Answered • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
Reportstack Contact contactus@reportstack.com
If you are interested...
Contact −
Sudha B
−
Email: contactus@reportstack.com
−
Ph:+1-888-789-6604
−
http://www.reportstack.com
Reportstack Contact contactus@reportstack.com